- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis ; volume:7 ; number:1 ; day:25 ; month:6 ; year:2020 ; pages:36-40 ; date:6.2020
Drugs - real world outcomes ; 7, Heft 1 (25.6.2020), 36-40, 6.2020
- Creator
-
Rose, Warren E.
Hutson, Paul R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-020-00188-6
- URN
-
urn:nbn:de:101:1-2020083120331729705455
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rose, Warren E.
- Hutson, Paul R.
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Blind estimation of pharmacokinetic parameters in cardiac DCE-MRI
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Pharmacokinetics, pharmacodynamics and immunodynamics of daclizumab in a two-dose regimen in liver transplantation
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma
The dose regimen formulation of doxycycline hydrochloride and florfenicol injection based on ex vivo pharmacokinetic-pharmacodynamic modeling against the Actinobacillus pleuropneumoniae in pigs
Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Blind estimation of pharmacokinetic parameters in cardiac DCE-MRI
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Pharmacokinetics, pharmacodynamics and immunodynamics of daclizumab in a two-dose regimen in liver transplantation
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma
The dose regimen formulation of doxycycline hydrochloride and florfenicol injection based on ex vivo pharmacokinetic-pharmacodynamic modeling against the Actinobacillus pleuropneumoniae in pigs
Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
Blind estimation of pharmacokinetic parameters in cardiac DCE-MRI
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Pharmacokinetics, pharmacodynamics and immunodynamics of daclizumab in a two-dose regimen in liver transplantation
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma
The dose regimen formulation of doxycycline hydrochloride and florfenicol injection based on ex vivo pharmacokinetic-pharmacodynamic modeling against the Actinobacillus pleuropneumoniae in pigs